Clinical Trial Update: Oral Ifetroban to Treat Aspirin Exacerbated Respiratory Disease (AERD) [Phase 2]

View source ↗

Summary

Phase 2 results update for an oral Ifetroban trial in aspirin-exacerbated respiratory disease (AERD), a condition that includes asthma and aspirin-induced sympt…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aspirin-exacerbated Respiratory Disease
• Asthma

Drugs mentioned

• Ifetroban (Ifetroban)

Snippet

Sponsor: Cumberland Pharmaceuticals | Conditions: Asthma, Aspirin-Induced | Phase 2 | Status: COMPLETED | Results posted: 2024-06-28